News for Healthier Living

Costs Still on the Rise for Drugs for Neurological Diseases

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS drugs, according to a study published in the October 30, 2024, online issue of Neurology(r), the medical journal of the American Academy of Neurology.

October 30, 2024


November 12 2024

November 11 2024

November 10 2024

November 9 2024

November 8 2024

November 7 2024

November 6 2024

November 5 2024

November 4 2024

November 3 2024

November 2 2024

November 1 2024

October 31 2024

October 30 2024